GlaxoSmithKline : A two-step process
>A conclusion for GSK OTC in India, at last - The unwinding has finally happened! After multiple rumours, GSK yesterday announced its exit from Horlicks and other nutrition products as well as a merger between GSK India and Hindustan Unilever Limited (“HULâ€). The total amount of the deal stands at £ 3.1bn for net proceeds estimated by the group at £ 2.4bn.Estimated net proceeds of £ 2.4bn for the deal - This divestment comes as no surprise. Several mo...GlaxoSmithKline is a global healthcare company. Co.'s segments include: Pharmaceuticals; Vaccines; and Consumer Healthcare. The Pharmaceuticals segment is focused on developing new medicines in respiratory, HIV, oncology and immuno-inflammation, with discovery research exploring these and other areas. The Vaccines segment has a portfolio and pipeline of vaccines to help protect people throughout life. Co. delivers vaccines to people living in over 160 countries. The Consumer Healthcare segment develops and markets consumer-preferred brands in oral health, pain relief, respiratory, nutrition/gastro-intestinal and skin health.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.